-
-
-
-
-
-
-
Oculis OCS-01 eye drops fail primary endpoints in diabetic macular edema trials
-
-
-
-
-
-
-
FDA places clinical hold on Aardvark Therapeutics ARD-101 drug trials
-
-
-
-
-
-
-
FDA proposes to exclude semaglutide, tirzepatide from compounding list
-
-
-
-
-
-
-
Regeneron wins FDA approval for gene therapy treating rare hearing loss
-
-
-
-
-
-
-
ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug
-
-
-
-
-
-
-
United Therapeutics TETON-1 study meets primary endpoint for lung disease treatment
-
-
-
-
-
-
-
Pfizer's TALZENNA combination shows progress against prostate cancer
-
5,981 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Hot FDA News reports.

